75 related articles for article (PubMed ID: 6852094)
21. Differential photoaffinity labelling of serotonin-S2 receptors and histamine-H1 receptors using 7-azidoketanserin.
Wouters W; Van Dun J; Leysen JE; Laduron PM
FEBS Lett; 1985 Mar; 182(2):291-6. PubMed ID: 3979551
[TBL] [Abstract][Full Text] [Related]
22. Comparison of iprindole, imipramine and mianserin action on brain serotonergic and beta adrenergic receptors.
Gandolfi O; Barbaccia ML; Costa E
J Pharmacol Exp Ther; 1984 Jun; 229(3):782-6. PubMed ID: 6327970
[TBL] [Abstract][Full Text] [Related]
23. Serotonergic, adrenergic and histaminergic receptors coupled to phospholipase C in cultured cerebellar granule cells of rats.
Xu J; Chuang DM
Biochem Pharmacol; 1987 Jul; 36(14):2353-8. PubMed ID: 3038121
[TBL] [Abstract][Full Text] [Related]
24. Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol.
Altar CA; Kim H; Marshall JF
J Pharmacol Exp Ther; 1985 May; 233(2):527-38. PubMed ID: 3889277
[TBL] [Abstract][Full Text] [Related]
25. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
List SJ; Seeman P
Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314
[TBL] [Abstract][Full Text] [Related]
26. High and low affinity 5-HT2 and 5-HT1C binding sites: responses to neonatal 5,7-DHT lesions in rat brain.
Pranzatelli MR; Gregory CM
Cytobios; 1993; 75(302-303):197-209. PubMed ID: 8243108
[TBL] [Abstract][Full Text] [Related]
27. Unusual acute effects of antidepressants and neuroleptics on S2-serotonergic receptors.
Helmeste DM; Tang SW
Life Sci; 1983 Dec; 33(25):2527-33. PubMed ID: 6139734
[TBL] [Abstract][Full Text] [Related]
28. Solubilization and characterization of the 5-hydroxytryptamine transporter complex from rat cerebral cortical membranes.
Habert E; Graham D; Langer SZ
Eur J Pharmacol; 1986 Mar; 122(2):197-204. PubMed ID: 2940096
[TBL] [Abstract][Full Text] [Related]
29. Physicochemical characterization of detergent-solubilized gamma-aminobutyric acid and benzodiazepine receptor proteins from bovine brain.
Stephenson FA; Watkins AE; Olsen RW
Eur J Biochem; 1982 Apr; 123(2):291-8. PubMed ID: 6281005
[TBL] [Abstract][Full Text] [Related]
30. High-affinity antagonists of the locust neuronal octopamine receptor.
Roeder T
Eur J Pharmacol; 1990 Nov; 191(2):221-4. PubMed ID: 2086239
[TBL] [Abstract][Full Text] [Related]
31. Solubilization and characterization of high-affinity [3H]serotonin binding sites from bovine cortical membranes.
VandenBerg SR; Allgren RL; Todd RD; Ciaranello RD
Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3508-12. PubMed ID: 6574495
[TBL] [Abstract][Full Text] [Related]
32. Phosphoinositide hydrolysis mediated by histamine H1-receptors in rat brain cortex.
Claro E; Arbonés L; García A; Picatoste F
Eur J Pharmacol; 1986 Apr; 123(2):187-96. PubMed ID: 3011460
[TBL] [Abstract][Full Text] [Related]
33. Are 5-hydroxytryptamine7 receptors involved in [3H]5-hydroxytryptamine binding to 5-hydroxytryptamine 1nonA-nonB receptors in rat hypothalamus?
Gobbi M; Parotti L; Mennini T
Mol Pharmacol; 1996 Mar; 49(3):556-9. PubMed ID: 8643096
[TBL] [Abstract][Full Text] [Related]
34. A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover.
Conn PJ; Sanders-Bush E; Hoffman BJ; Hartig PR
Proc Natl Acad Sci U S A; 1986 Jun; 83(11):4086-8. PubMed ID: 2940597
[TBL] [Abstract][Full Text] [Related]
35. [3H]SCH 23390 labels a novel 5-hydroxytryptamine binding site in human blood platelet membranes.
De Keyser J; Walraevens H; Convents A; Ebinger G; Vauquelin G
Eur J Pharmacol; 1989 Mar; 162(3):437-45. PubMed ID: 2568263
[TBL] [Abstract][Full Text] [Related]
36. Characterization of [3H]5-hydroxytryptamine and [3H]spiperone binding sites in clathrin-coated vesicles from bovine brain.
Moroi K; Ozaki N; Kadota T; Kadota K
Brain Res; 1998 Jun; 794(2):291-8. PubMed ID: 9622654
[TBL] [Abstract][Full Text] [Related]
37. D1 dopamine receptors in human putamen, frontal cortex and calf retina: differences in guanine nucleotide regulation of agonist binding and adenylate cyclase stimulation.
De Keyser J; Dierckx R; Vanderheyden P; Ebinger G; Vauquelin G
Brain Res; 1988 Mar; 443(1-2):77-84. PubMed ID: 2896059
[TBL] [Abstract][Full Text] [Related]
38. Putative selective 5-HT-2 antagonists block serotonin 5-HT-1c receptors in the choroid plexus.
Sanders-Bush E; Breeding M
J Pharmacol Exp Ther; 1988 Oct; 247(1):169-73. PubMed ID: 3139864
[TBL] [Abstract][Full Text] [Related]
39. Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist.
Pranzatelli MR
Biochem Pharmacol; 1991 Aug; 42(5):1099-105. PubMed ID: 1872895
[TBL] [Abstract][Full Text] [Related]
40. Genetic control of dopamine and serotonin receptors in brain regions of inbred mice.
Boehme RE; Ciaranello RD
Brain Res; 1983 Apr; 266(1):51-65. PubMed ID: 6850346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
